1. Home
  2. EML vs XBIT Comparison

EML vs XBIT Comparison

Compare EML & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

HOLD

Current Price

$24.91

Market Cap

152.9M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.16

Market Cap

70.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EML
XBIT
Founded
1858
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
70.1M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
EML
XBIT
Price
$24.91
$2.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.6K
43.1K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
N/A
EPS
1.04
N/A
Revenue
$248,970,345.00
N/A
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$2.09
52 Week High
$29.91
$3.44

Technical Indicators

Market Signals
Indicator
EML
XBIT
Relative Strength Index (RSI) 42.81 42.52
Support Level $24.10 N/A
Resistance Level $27.16 $2.46
Average True Range (ATR) 1.36 0.05
MACD -0.25 -0.00
Stochastic Oscillator 16.23 23.53

Price Performance

Historical Comparison
EML
XBIT

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: